Who owns IKENA ONCOLOGY INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Ikena Oncology with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Ikena Oncology stock

Who bought or sold IKENA ONCOLOGY INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Atlas Venture Life Science Advisors 5.0M $8.3M 0% Jun 2024
 View chart
BVF 4.8M $8.3M 0% Sep 2024
 View chart
Blue Owl Capital Holdings 4.1M $7.1M 0% Sep 2024
 View chart
OrbiMed Advisors 3.5M $6.1M 0% Sep 2024
 View chart
Omega Fund Management 2.2M $3.7M 0% Jun 2024
 View chart
Vanguard Group 1.4M $2.3M -11% Jun 2024
 View chart
BML Capital Management 723k $1.3M 24% Sep 2024
 View chart
NEA Management Company 600k $1.0M 5% Sep 2024
 View chart
Acuitas Investments 450k $778k 12% Sep 2024
 View chart
Renaissance Technologies 401k $693k -16% Sep 2024
 View chart
Jacobs Levy Equity Management 389k $673k -8% Sep 2024
 View chart
Sofinnova Ventures 383k $662k 0% Sep 2024
 View chart
BlackRock 355k $586k -81% Jun 2024
 View chart
BlackRock 352k $609k 100% Sep 2024
 View chart
Acadian Asset Management 326k $562k 0% Sep 2024
 View chart
Goldman Sachs Group 274k $452k 277% Jun 2024
 View chart
Geode Capital Management 271k $469k 6% Sep 2024
 View chart
Two Sigma Investments 237k $391k -3% Jun 2024
 View chart
FNY Investment Advisers 231k $400k 100% Sep 2024
 View chart
Barclays 195k $338k 0% Sep 2024
 View chart
Two Sigma Advisers 173k $286k 117% Jun 2024
 View chart
Citadel Advisors 165k $286k -33% Sep 2024
 View chart
Verition Fund Management 135k $223k -88% Jun 2024
 View chart
BBR Partners 130k $225k 550% Sep 2024
 View chart
Bridgeway Capital Management 82k $136k 0% Jun 2024
 View chart
Deuterium Capital Management 81k $133k 100% Jun 2024
 View chart
State Street Corporation 80k $133k -83% Jun 2024
 View chart
Marquette Asset Management 73k $126k 0% Sep 2024
 View chart
JBF Capital 73k $120k 100% Jun 2024
 View chart
Alpine Partners VI 65k $107k 100% Jun 2024
 View chart
Susquehanna International 57k $99k -31% Sep 2024
 View chart
Northern Trust 48k $83k -79% Sep 2024
 View chart
Morgan Stanley 41k $67k -17% Jun 2024
 View chart
Dimensional Fund Advisors 39k $67k 0% Sep 2024
 View chart
Jane Street 37k $65k -33% Sep 2024
 View chart
Qube Research & Technologies 35k $58k 100% Jun 2024
 View chart
Squarepoint Ops 28k $46k 100% Jun 2024
 View chart
Corsair Capital Management 25k $43k 100% Sep 2024
 View chart
Point72 Asia 22k $38k -51% Sep 2024
 View chart
Tower Research Capital 20k $33k 125% Jun 2024
 View chart
JustInvest 18k $31k -3% Sep 2024
 View chart
Charles Schwab Investment Management 12k $21k 0% Sep 2024
 View chart
LPL Financial 12k $21k 100% Sep 2024
 View chart
Point72 6.7k $12k 53% Sep 2024
 View chart
Russell Investments 2.3k $3.8k 100% Jun 2024
 View chart
Macquarie Group 1.6k $2.6k 100% Jun 2024
 View chart
Advisor Group Holdings 1.5k $2.6k 100% Sep 2024
 View chart
Jpmorgan Chase & Co 849.00 $1.5k 0% Sep 2024
 View chart
SRS Capital Advisors 299.00 $517.987600 0% Sep 2024
 View chart
Bank of America Corporation 199.00 $343.991400 -39% Sep 2024
 View chart
Farther Finance Advisors 108.00 $187.002000 -36% Sep 2024
 View chart
NISA Investment Advisors 99.00 $171.002700 0% Sep 2024
 View chart

Who sold out of Ikena Oncology?

Fund or Company Name Date Sold Shares Held Valued At
Millennium Management Jun 2024 355k $585k
Centiva Capital Jun 2024 73k $121k
Y-Intercept Jun 2024 61k $100k
Marshall Wace Jun 2024 45k $74k
Nuveen Asset Management Mar 2024 36k $52k
Sunrise Partners Limited Partnership Jun 2024 30k $50k
Virtu Financial Jun 2024 28k $46k
Hrt Financial Jun 2024 27k $44k
AQR Capital Management Jun 2024 22k $36k
XTX Topco Jun 2024 17k $27k
Mirae Asset Global Etfs Holdings Jun 2024 16k $27k
Citigroup Jun 2024 5.0k $8.3k
Cubist Systematic Strategies Jun 2024 4.8k $8.0k
Rhumbline Advisers Jun 2024 3.9k $6.4k
CWM Jun 2024 985.00 $2.0k
New York State Common Retirement Fund Jun 2024 283.00 $0